1. Home
  2. ARDX vs LCLN Comparison

ARDX vs LCLN Comparison

Compare ARDX & LCLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.02

Market Cap

797.8M

Sector

Health Care

ML Signal

N/A

Logo Lincoln International Inc. Class A Common Stock

LCLN

Lincoln International Inc. Class A Common Stock

N/A

Current Price

$25.88

Market Cap

821.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ARDX
LCLN
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
797.8M
821.7M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
ARDX
LCLN
Price
$3.02
$25.88
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$12.80
★ $27.07
AVG Volume (30 Days)
★ 4.3M
222.4K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
★ 1.08%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,607,000.00
N/A
Revenue This Year
$19.21
$28.20
Revenue Next Year
$28.19
$15.26
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$20.05
52 Week High
$8.40
$27.55

Technical Indicators

Market Signals
Indicator
ARDX
LCLN
Relative Strength Index (RSI) 40.04 64.18
Support Level N/A $22.92
Resistance Level $3.35 $27.49
Average True Range (ATR) 0.12 0.86
MACD 0.01 0.26
Stochastic Oscillator 25.32 90.85

Price Performance

Historical Comparison
ARDX
LCLN

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About LCLN Lincoln International Inc. Class A Common Stock

Lincoln International Inc is an independent investment banking advisory company focused on private capital markets. The company operates its business through its two operating segments: Investment Banking Advisory and Valuations and Opinions. The Investment Banking Advisory segment offers a range of services related to mergers and acquisitions, with key areas of focus including sell-side advisory, buy-side advisory, asset sales and divestitures, restructuring, primary and secondary capital raising, and merger-related engagements. The Valuations and Opinions segment provides valuation services to investment funds and financial institutions. The majority of revenue is derived from the Investment Banking Advisory segment. Geographically, the maximum revenue is derived from the Americas.

Share on Social Networks: